Found 5 results
Filters: Author is Lexchin,J.  [Clear All Filters]
Mintzes B, Lexchin J, Sutherland J, Beaulieu M, Wilkes M, Durrieu G, et al. Pharmaceutical Sales Representatives and Patient Safety: A Comparative Prospective Study of Information Quality in Canada, France and the United States. Journal of General Internal Medicine. 2013.
Morgan SG, Grootendorst P, Lexchin J, Cunningham C, Greyson D. The cost of drug development: a systematic review. Health Policy. 2011;100(1):4-17.
Mintzes B, Barer ML, Lexchin J, Bassett KL. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy. Research in social & administrative pharmacy : RSAPRes.Social Adm.Pharm.. 2005;1(2):310-330.
Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A, et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienneCMAJ. 2003;169(5):405-412.
Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, et al. Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey. BMJ (Clinical research ed.)BMJ. 2002;324(7332):278-279.